AstaLynx Global

New York, United States
Provides pharmacovigilance, regulatory, and tech services to biopharma firms worldwide.
Annual revenue $1.2M Latest available
Total funding - Funding intelligence
Employees 54 Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors 10 Brand Intelligence

About AstaLynx Global

AstaLynx Global is a company based in New York (United States). It operates as a B2B and SaaS. The company has 54 employees as of March 31, 2023. AstaLynx Global offers products and services including ADRium Intake, ADRium Safety, ADRium Signals, ADRium Analytics, and Caspian Data Lake. AstaLynx Global operates in a competitive market with competitors including ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.

  • Headquarter New York, United States
  • Employees 54 as on 31 Mar, 2023
  • Sectors
    Technology
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Synapmed Global Private Limited
  • Date of Incorporation 21 Feb, 2020
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Technology → Cloud, Data & Analytics Infrastructure Unlock Sub-Sector Unlock Segment
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.23 M (USD)
    58.12
    as on Mar 31, 2023
  • Net Profit
    $116.21 K (USD)
    1638.7
    as on Mar 31, 2023
  • EBITDA
    $226.71 K (USD)
    1182.19
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    54

    as on Mar 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AstaLynx Global

AstaLynx Global offers a comprehensive portfolio of products and services, including ADRium Intake, ADRium Safety, ADRium Signals, ADRium Analytics, and Caspian Data Lake.

Product name locked
Category locked
Primary

Platform for managing adverse event intake and reporting.

Product name locked
Category locked
Locked

Tool for comprehensive pharmacovigilance operations and monitoring.

Product name locked
Category locked
Locked

System for detecting and managing safety signals in drugs.

Product name locked
Category locked
Locked

Service for analyzing safety data to inform decisions.

Product name locked
Category locked
Locked

Repository for real-world data analytics in life sciences.

Funding Insights of AstaLynx Global

Premium access

Detailed funding history for AstaLynx Global

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by AstaLynx Global

Investments
Premium access

Investment portfolio details for AstaLynx Global

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - AstaLynx Global

Premium access

Detailed financials for AstaLynx Global

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Astalynx Global Comparisons

AstaLynx Global Primary company
Description
Provides pharmacovigilance, regulatory, and tech services to...
Location
New York, United States
Founded Year
-
Annual Revenue
$1.23 M (USD)
Net Profit
$116.21 K (USD)
EBITDA
$226.71 K (USD)
Employees
54
As of 2023
Premium access

Peer comparison for AstaLynx Global

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of AstaLynx Global

AstaLynx Global operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ProPharma Group, Validant, PharmaLex, Technical Safety Services and Celegence, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device
Locked Locked Locked
Regulatory, compliance, and quality consulting for GxP lifecycles is provided.
Locked Locked Locked
CRO specializing in regulatory affairs and pharmacovigilance
Locked Locked Locked
Healthcare instrumentation, medical gas systems, and related devices are manufactured.
Locked Locked Locked
Regulatory consulting and solutions for pharmaceuticals and medical devices compliance.
Locked Locked Locked
Provides radiopharmaceutical equipment, synthesis solutions, and custom services for labs.
Premium access

Detailed competitors of AstaLynx Global

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Astalynx Global

Premium access

Complete news archive for AstaLynx Global

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about AstaLynx Global

AstaLynx Global is headquartered in New York, United States. It is registered at New York, New York, United States.

As of Mar 31, 2023, the latest employee count at AstaLynx Global is 54.

Annual revenue of AstaLynx Global is $1.23M as on Mar 31, 2023.

Synapmed delivers AI-powered solutions for pharmacovigilance, drug safety, and regulatory compliance, supporting biopharma companies in research, clinical trials, and commercialization. They leverage real-world data analytics and technology implementation to ensure efficient decision-making and adherence to standards. Based in the USA and India, Synapmed serves life sciences clients with expert teams for pre-clinical to post-market activities.

AstaLynx Global's top competitors include ProPharma Group, PharmaLex and Pharma-Bio Serv.

AstaLynx Global offers ADRium Intake, ADRium Safety, ADRium Signals, ADRium Analytics, and Caspian Data Lake.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available